User:Mr. Ibrahem/Pegvaliase

Pegvaliase, sold under the brand name Palynziq, is a medication used to treat phenylketonuria. It is used when other treatments, including diet and sapropterin, are not sufficient. It is given by injection under the skin.

Common side effects include pain at the site of injection, joint pain, and allergic reactions. Other side effects may include anaphylaxis, angioedema, and serum sickness. It is unclear if use during pregnancy is safe for the baby. It is the enzyme phenylalanine ammonia lyase connected to polyethylene glycol and works by breaking down phenylalanine.

Pegvaliase was approved for medical use in the United States in 2018 and Europe in 2019. It is not available in the United Kingdom as of 2021. In the United States it costs about 560 USD per dose up to 20 mg as of 2021.